
pmid: 2509720
pmc: PMC2571577
Swainsonine, an indolizidine alkaloid with immunomodulatory activity, has been found to be effective in inhibiting metastatic dissemination and growth of primary tumors of both murine and human origins. The unique ability of swainsonine to exhibit antimetastatic, anti-proliferative, and immunomodulatory activity imparts this drug a promising future in cancer therapy.
Swainsonine, Cell Membrane, Oligosaccharides, Antineoplastic Agents, Breast Neoplasms, Inbred C57BL, Cell Line, Mice, Inbred C57BL, Mice, Alkaloids, Transformed, Adjuvants, Immunologic, Immunologic, Animals, Humans, Adjuvants, Neoplasm Metastasis, Cell Line, Transformed
Swainsonine, Cell Membrane, Oligosaccharides, Antineoplastic Agents, Breast Neoplasms, Inbred C57BL, Cell Line, Mice, Inbred C57BL, Mice, Alkaloids, Transformed, Adjuvants, Immunologic, Immunologic, Animals, Humans, Adjuvants, Neoplasm Metastasis, Cell Line, Transformed
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 6 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
